Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Incontinence, prolapse & sacral neuromodulation · Oregon | Incontinence, prolapse & sacral neuromodulation · California | |
|---|---|---|
| Surgeons, 2024 | 11 | 73 |
| Medicare fee-for-service cases | 883 | 5,242 |
| Growth since 2019 (Medicare FFS) | −0.6%/yr | +0.1%/yr |
| Forecast cases (Medicare FFS) | 1,300 in 2030 | 6,070 in 2030 |
| Forecast growth | +6.6%/yr to 2030 | +2.5%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 2.1 | 1.6 |
| Medicare Advantage share | 59% | 56% |
| Out of hospital | 21% (+19 pts since 2019) | 20% (+9 pts since 2019) |
| Cases per surgeon | 80 | 72 |
| Top 10 surgeons' share | 97% | 39% |
| Surgeons growing | 3 | 16 |
| New since the base year | 0 | 9 |
| Likely to stop billing it | 5 by 2026 | 21 by 2026 |
| Forecast miss, 1 year (procedure) | 6% | 6% |
| Company payments per surgeon | $3,653 | $13K |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.